chromosome research

summary

Our genetic material (DNA) is packaged into compact structures known as chromosomes, through which all the activities of our genes are regulated. Defects in chromosome number or the way chromosomes are packaged cause a plethora of problems, such as the imbalanced distribution of our genetic material and aberrant gene activity, giving rise to many serious clinical outcomes including cancer, dysmorphology, intellectual disability, infertility, and pregnancy loss. This research aims to study the mechanisms that control the functions of chromosomes and their underlying genes, the clinical impact of their dysfunction, and potential interventional strategies

group leader(s)

Andy Choo

  Professor KH Andy Choo
  Director, Genetic Disorders Theme
  Murdoch Childrens Research Institute
  Department of Paediatrics, University of Melbourne
  The Royal Children's Hospital
  Flemington Road Parkville
  Victoria 3052
  Australia

  T +61 3 8341 6306
  F +61 3 8341 6212
  E andy.choo@mcri.edu.au

group leader biography

current research projects

Project 1: Master regulator of chromosome compaction, DNA repair and gene expression, and impact on disease aetiology

In order for our genetic material to be faithfully segregated into two daughter cells, the DNA must compact 10,000 fold into chromosomes. Proper compaction of DNA also underpins the regulation of DNA repair and global gene expression. A master regulator in these fundamentally important processes is the multi-subunit protein complex, condensin, for which an increasing number of diseases have now been linked to its defect. The aims of this project are to understand how condensin and its affiliated components affect chromosome folding, DNA repair and global gene expression, using integrated proteomics, biochemistry and cell biology approaches. Specific techniques employed will include RNAi and conditional gene knockout, expression array analysis, next gen sequencing, and others. The knowledge gained will have major implications for understanding the underlying causes of a wide range of diseases.

Contact: damien.hudson@mcri.edu.au or andy.choo@mcri.edu.au

Project 2: Chromosome instability and disorders of the sex chromosomes and sexual development

Chromosomes must be copied and distributed faultlessly into the newly dividing cells for normal human development to occur. Failure of the accurate segregation of chromosomes is linked to many health problems including birth defects, cancer, premature aging and infertility. This project aims to identify genetic and epigenetic factors that compromise the faithful transmission of chromosomes in humans and mice, with a focus on disorders of the sex chromosomes and sexual development. The study will utilise state-of-the-art genetic and epigenetic approaches and tools including live-cell imaging, cell and chromosome sorting, proteomics, and mutant gene identification and characterisation. Results gained from this project have the potential to benefit the diagnosis and prevention of a host of chromosome-related disorders.

Contact: paul.kalitsis@mcri.edu.au or andy.choo@mcri.edu.au

Project 3: Epigenetic regulation in normal and stem cells, and in cancers

This research involves the investigation of the epigenetic mechanisms that control gene transcription, chromatin organisation (with particular focus on the centromere and telomere), stem cell pluripotency and differentiation states, and cancer development. Specific project areas are:

a) We have previously reported that normal genomic DNA can undergo epigenetic transformation into a centromere (or neocentromere) with major consequence in genetic perturbation that results in birth disorders or cancer development. This study investigates the underlying roles of different epigenetic determinants including non-coding RNA, histone variants, and other chromatin modifiers. The findings will impact on our understanding of fundamental epigenetic mechanisms that regulate our chromatin environment, and their contribution to different disease conditions.

b) How pluripotent embryonic stem (ES) cells and cancer cells retain their capacity for indefinite proliferation is a central question in stem cell and cancer biology. We have shown the importance of histone variant H3.3 and ATRX (alpha thalassemia mental retardation) in the control of telomere function in ES cells, and the presence of H3.3 and ATRX at the telomeres of commonly occurring human ALT (alternative lengthening of telomeres) cancer cells. We propose and aim to test the hypothesis that ALT and possibly other cancers utilise a similar mechanism as ES cells in the regulation of telomere chromatin to ensure continual proliferation. We will determine the mechanisms of action between these chromatin regulators and how they contribute to the regulation of telomere length in ES cells and human cancers.

team members

  • Melissa Anderson - Research Assistant
  • Muhammed Bakhrebah - PhD Student (UoM Paeds)
  • Nicole Carson - Research Assistant
  • Fiona Chang - PhD Student (UoM Paeds)
  • Cw Chow - HONORARY FELLOW
  • Helen Godsall - Personal Assistant
  • Alison Graham - Research Assistant
  • Damien Hudson - Senior Research Officer
  • Danielle Irvine - Senior Research Officer
  • Paul Kalitsis - Senior Research Officer
  • Bo Won Kim - Research Assistant
  • Ji Hun Kim - PhD Student (UoM Paeds)
  • Danuta Loesch-Mdzewska - HONORARY FELLOW
  • William Marrow - Undergraduate Work Experience
  • Hua Ren - HONORARY FELLOW
  • David Tremethick - HONORARY FELLOW
  • Bob Williamson - ESTEEMED HONORARY FELLOW
  • Lee Wong - HONORARY FELLOW

publications

  • Marshall OJ., Choo KH. Putative CENP-B paralogues are not present at mammalian centromeres. Chromosoma (2011) PubMed
  • Yik YI., Farmer PJ., King SK., Chow CW., Hutson JM., Southwell BR. Gender differences in reduced substance P (SP) in children with slow-transit constipation. PEDIATRIC SURGERY INTERNATIONAL 27 (7) : 699 - 704(2011) PubMed
  • Zacharin M., Bajpai A., Chow CW., Catto-Smith A., Stratakis C., Wong MW., Scott R. Gastrointestinal polyps in McCune Albright syndrome. JOURNAL OF MEDICAL GENETICS 48 (7) : 458 - 461(2011) PubMed
  • Zaratiegui M., Castel SE., Irvine DV (2nd author)., Kloc A., Ren J., Li F., de Castro E., MarĂ­n L., Chang AY., Goto D., Cande WZ., Antequera F., Arcangioli B., Martienssen RA. RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II. Nature 479 (7371) : 135 - 138(2011) PubMed